Programmed death ligand 1 (PD-L1) as an immunotherapy target in patients with glioblastoma.

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Vlahovic, G; Fecci, PE; Reardon, D; Sampson, JH

Published Date

  • August 2015

Published In

Volume / Issue

  • 17 / 8

Start / End Page

  • 1043 - 1045

PubMed ID

  • 25964311

Pubmed Central ID

  • 25964311

Electronic International Standard Serial Number (EISSN)

  • 1523-5866

Digital Object Identifier (DOI)

  • 10.1093/neuonc/nov071

Language

  • eng

Conference Location

  • England